Levothyroxine sodium tablets are indicated for replacement therapy in primary, secondary, and tertiary congenital or acquired hypothyroidism. They are also used as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
Mechanism of Action
Absorption of orally administered levothyroxine sodium ranges from 40% to 80%. The majority of the dose is absorbed from the jejunum and upper ileum. Absorption is increased by fasting and decreased by malabsorption syndromes and dietary fiber. Thyroid hormones exert their physiologic actions through control of DNA transcription and protein synthesis. Triiodothyronine (T3) and L-thyroxine (T4) diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. The physiological actions of thyroid hormones are produced predominantly by T3.
Pharmacokinetics
Oral levothyroxine sodium is a synthetic T4 hormone that maintains normal T4 levels when a deficiency is present. Metabolism of T4 is primarily through sequential deiodination, with approximately 80% of circulating T3 derived from T4. Elimination of thyroid hormones occurs slowly, with excretion into the bile and gut. Administration is once daily, preferably on an empty stomach, and at least 4 hours before or after drugs that interfere with absorption. T3 and T4 are key regulators of thyroid function.